SCHEMBL25264635

SCHEMBL25264635

COc1ccc(C(C)NS(=O)(=O)c2ccc(O)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.60
CA1 P00915 3/20 0.59
CA2 P00918 3/20 0.59
ACHE P22303 1/20 0.59
MMP2 P08253 7/20 0.58
CA12 O43570 2/20 0.58
CA9 Q16790 2/20 0.58
CA14 Q9ULX7 2/20 0.58
GAA P10253 1/20 0.57
PKM P14618 1/20 0.57
MMP9 P14780 5/20 0.53
MMP8 P22894 5/20 0.53
MMP13 P45452 4/20 0.53
MMP1 P03956 3/20 0.53
MMP3 P08254 2/20 0.52
MMP7 P09237 2/20 0.52
CNR2 P34972 5/20 0.52
DRD4 P21917 1/20 0.52
DRD3 P35462 1/20 0.52
HTR6 P50406 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25193424 1.00 CNR1 (0.60) CNR1CA1CA2ACHEMMP2
SCHEMBL29259797 0.92 CA1 (0.68) CNR1CA1CA2ACHEMMP2
SCHEMBL28354122 0.87 CNR1 (0.77) CNR1CA1CA2ACHEMMP2
SCHEMBL29259802 0.85 CNR1 (0.60) CNR1CA1CA2ACHEMMP2
SCHEMBL25181527 0.85 CA1 (0.63) CNR1CA1CA2ACHEMMP2
SCHEMBL29259799 0.85 CNR1 (0.60) CNR1CA1CA2ACHEMMP2
SCHEMBL25181528 0.85 CA1 (0.63) CNR1CA1CA2ACHEMMP2
SCHEMBL29259795 0.85 CNR1 (0.60) CNR1CA1CA2ACHEMMP2
SCHEMBL11065834 0.85 CNR1 (0.70) CNR1CA1CA2ACHEMMP2
SCHEMBL29260162 0.83 CNR1 (0.61) CNR1CA1CA2ACHEMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240382474-A1 ENPP1 MODULATORS AND USES THEREOF VIR BIOTECHNOLOGY INC (US) 2024-11-21 US disclosed
EP-4433455-A1 ENPP1 MODULATORS AND USES THEREOF VIR Biotechnology, Inc. (US) 2024-09-25 EP disclosed
WO-2023225001-A1 NAPHTHYRIDINE BASED ENPP1 MODULATORS AND USES THEREOF Vir Biotechnology, Inc. (US) 2023-11-23 WO disclosed
WO-2023086638-A1 ENPP1 MODULATORS AND USES THEREOF Vir Biotechnology, Inc. (US) 2023-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240382474-A1 ENPP1 MODULATORS AND USES THEREOF ENPP1, ENPP2, ENPP3 CNR1 2268/4885CA1 4856/4885CA2 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.